Clinical Trials Logo

Clinical Trial Summary

This is an open phase III randomized clinical trial studying the superiority of management by immunomodulator treatment of psychiatric disorders (psychosis and bipolar disorders) for patients previously identified as carriers of autoimmunity such as as the presence of a pathogenic anti-glutamatergic NMDA receptor antibody (NMDAr-Ac).


Clinical Trial Description

This is an open phase III randomized clinical trial studying the superiority of management by immunomodulator treatment of psychiatric disorders (psychosis and bipolar disorders) for patients previously identified as carriers of autoimmunity such as as the presence of a pathogenic anti-glutamatergic NMDA receptor antibody (NMDAr-Ac). The aim is to assess the clinical efficacy of this treatment associated with the usual recommended psychotropic treatment. To meet this objective, we will use, via a National Center for Scientific Research (CNRS) Research laboratory in Bordeaux, a very sensitive diagnostic platform to detect and demonstrate the pathogenesis of antibodies in patient serum. This platform is operational only within the framework of validation of the results by the reference center for neurological autoimmune diseases in Lyon ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05946486
Study type Interventional
Source University Hospital, Bordeaux
Contact Frédéric VILLEGA, MD, PhD
Phone +33 (0)5 56 79 56 41
Email frederic.villega@chu-bordeaux.fr
Status Not yet recruiting
Phase Phase 3
Start date October 15, 2023
Completion date December 15, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06102850 - Adaptation of Critical Time Intervention for Young Adults With MH Challenges N/A
Completed NCT05649449 - Testing Self-Directed Care in Florida N/A
Not yet recruiting NCT05886595 - Being Young : My Mental Health
Recruiting NCT04157062 - An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder N/A
Completed NCT04505540 - Start Treatment and Recovery for Opioid Use Disorder N/A
Withdrawn NCT03236766 - Engaging Pacific Islander Perspectives on Mental Illness and Mental Health Services N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Not yet recruiting NCT04071145 - Using Sensors to Measure Drug Concentrations in Exhaled Breath
Completed NCT01922258 - Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Phase 3
Completed NCT04457635 - Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders. N/A
Recruiting NCT06054061 - Evaluation the Efficacy "Think and Cope Positively" Program N/A
Completed NCT03118388 - Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs Phase 2
Active, not recruiting NCT04196881 - Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers N/A
Terminated NCT04028609 - Community Health Worker Intervention to Improve Post-Hospital Outcomes N/A
Active, not recruiting NCT03641664 - FCT Study: Reducing the Need for Out-of-Home Placements N/A
Completed NCT05019937 - Exploring Effectiveness and Mechanism of Change of an Implementation Strategy on Guideline Implementation in Schools N/A
Completed NCT03611998 - Survivors of Sex Trafficking: Occupation-Based Interventions for Executive Functioning N/A
Active, not recruiting NCT04148508 - App-based Mental Health Promotion in Young European Adults N/A
Completed NCT03704805 - Effect of a Psychological Intervention on Antiretroviral Therapy and Mental Health Outcomes in HIV-positive Adults in Zimbabwe N/A
Recruiting NCT05087446 - Effect of Early Assessment Team for Patients Referred to Outpatient Mental Health Care N/A